Articles by Daniel Marsh
DoorDash Stock Steady After ICE Shooting Confirms Delivery Driver
DoorDash confirmed the man shot by an ICE officer in Austin was making a delivery. DASH shares saw minimal premarket movement, but the incident could impact courier safety policies.
Walmart Expands Rural Health Pilot to Five Stores in Six-Month Trial
Walmart is testing health ambassadors in five rural stores to improve access to care. The six-month pilot could signal a broader healthcare strategy.
DoorDash's Nevada Reincorporation Shifts Governance, Not Fundamentals
DoorDash moved its corporate home to Nevada, altering governance rules but not its business. Q2 revenue jumped 36%, though net income fell. The stock dipped slightly.
Jev's Rapid Adoption Raises Questions for Cloudflare's AI Revenue
Jev, a new AI model from TypeSafe, quickly gained traction on Vercel's gateway, but undisclosed revenue terms and pricing sustainability questions loom for Cloudflare.
Craneware Tumbles 24% After Cyber Incident and 340B Woes Trigger Revenue Reset
Craneware shares fell 23.7% to 1,024p after resetting FY2027 revenue to $185M, citing a 340B market slowdown and a cyber incident. Net revenue retention dropped to 100% from 107%.
IHG Cancels 80K Shares in $12.2M Buyback as Net Debt Rises to $3.66B
InterContinental Hotels Group (IHG) spent $12.2M on a routine buyback, retiring 0.054% of shares. Net debt rose to $3.66B, but H1 EPS grew 13%. Analysts see upside.
Novo Nordisk Shares Drop 5% as 2030 Strategy Omits Growth Target
Novo Nordisk shares slid 5% after its 2030 strategy omitted a numeric growth target, focusing instead on pipeline diversification and launches.
Nordnet's Modest Buyback Spurs 4.2% Share Rally
Nordnet shares rose 4.2% on a modest buyback announcement, but the program's small size raises questions about its impact. Analysts' targets vary widely.
Ipsen Drops 7% as Amneal Launches Somatuline Generic
Ipsen shares dropped 7.3% after Amneal launched a generic version of its top-selling drug Somatuline Depot, erasing €955 million in market value.
Greenland Mines Soars 73% on Arctic Pact, Yet Risks Loom
GRML jumped 73% premarket to $4.92 on a pending Arctic security pact, but the pact is unsigned and offers no financial commitments. Dilution risks remain.
Berentzen Shares Surge 22% as Sazerac Bids €5.55 in Cash
Berentzen shares soared 22.3% to €5.54 after Sazerac's €5.55 cash bid, leaving a razor-thin 0.18% spread. Heavy volume signals market confidence in deal closure.